Article Link: FDA Approves Epclusa (sofosbuvir/velpatasvir) for Children Ages 6 and Older or Weighing at Least 17 kg with Chronic Hepatitis C Infectio...
FDA Approves Ofev (nintedanib) as First Treatment for Chronic Fibrosing Interstitial Lung Diseases (ILDs) with a Progressive Phenotype
Article Link: FDA Approves Ofev (nintedanib) as First Treatment for Chronic Fibrosing Interstitial Lung Diseases (ILDs) with a Progressive Phenotype...
FDA Approves Ofev (Nintedanib), For The Treatment of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype
Article Link: FDA Approves Ofev (Nintedanib), For The Treatment of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype ...
FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease
Article Link: FDA Approves Isturisa (osilodrostat) for the Treatment of Cushing’s Disease March 06, 2020 — The U.S. Food and Drug A...
FDA Approves Durysta (bimatoprost implant) to Lower Intraocular Pressure In Open-Angle Glaucoma or Ocular Hypertension Patients
Article Link: FDA Approves Durysta (bimatoprost implant) to Lower Intraocular Pressure In Open-Angle Glaucoma or Ocular Hypertension Patients ...
Tiny Float Biopharma Stock Exhibiting Value and Paying a Stock Dividend Real Soon
Tiny Float Biopharma Stock Exhibiting Value Spherix is paying a stock dividend real soon Good day everyone, Today we are initiating coverage of Spheri...
FDA Approves Sarclisa (isatuximab-irfc) for Patients with Relapsed Refractory Multiple Myeloma
Article Link: FDA Approves Sarclisa (isatuximab-irfc) for Patients with Relapsed Refractory Multiple Myeloma BRIDGEWATER, N.J., March 2, ...
FDA Approves Advil Dual Action (ibuprofen and acetaminophen) as an Over-the-Counter Pain Treatment
Article Link: FDA Approves Advil Dual Action (ibuprofen and acetaminophen) as an Over-the-Counter Pain Treatment WARREN, N.J., Feb. 28, 2...
FDA Approves Nurtec ODT (rimegepant) for the Acute Treatment of Migraine in Adults
Article Link: FDA Approves Nurtec ODT (rimegepant) for the Acute Treatment of Migraine in Adults NEW HAVEN, Conn., Feb. 27, 2020 /PRNewsw...
FDA Approves Barhemsys (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting
Article Link: FDA Approves Barhemsys (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting Cambridge, UK an...